Asset Details
Do you wish to reserve the book?
A Routine over the Counter Phenylephrine Causing Rarer Drug Eruption as Adverse Drug Reaction-A Case Report
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Routine over the Counter Phenylephrine Causing Rarer Drug Eruption as Adverse Drug Reaction-A Case Report
Do you wish to request the book?
A Routine over the Counter Phenylephrine Causing Rarer Drug Eruption as Adverse Drug Reaction-A Case Report
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
A Routine over the Counter Phenylephrine Causing Rarer Drug Eruption as Adverse Drug Reaction-A Case Report
2023
Overview
Introduction: Adverse drug responses are unpleasant side effects of commonly used or recently begun medications, and they are most often in the skin. Cutaneous drug responses (CDR) are widespread and often manifest as moderate, self-limiting lesions, however, certain severe versions can be fatal [1-2]. Multiple medications with similar chemical structures can create some types of lesions. Lips, legs, hands, cheeks, genitalia, and oral mucosa are common sites for lesions that generate a burning sensation. Bullae can form as a result of a fixed medication eruption (EDE). Intranasal injection of phenylephrine resulted in fast systemic absorption, which is linked with a clinically modest elevation in blood pressure [3]. Case Presentation: Here we discuss a case of a 19-year-old female patient who reported to our hospital with blebs on the skin throughout her legs and torso. The drug eruption or adverse drug response was linked with itching, had a slow beginning, and progressed. Her medical history indicated that she had been taking phenylephrine 10 mg orally twice a day. On the sixth day, she experienced an adverse medication response caused by the medicine phenylephrine. Phenylephrine was stopped immediately and the other medications, such as levocetirizine, montelukast, and nasal spray, were continued. The patient was told not to use phenylephrine, either alone or in combination with FDCs. There are no other complaints. As a result, the patient was diagnosed with phenylephrine-induced eruption. Conclusion: We present this case to highlight the importance of inspiring a pharmacovigilance mindset among all clinicians providing care as an alert routine drug, phenylephrine-induced drug eruption.
